These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23863167)

  • 1. Pseudokinases from a structural perspective.
    Taylor SS; Shaw A; Hu J; Meharena HS; Kornev A
    Biochem Soc Trans; 2013 Aug; 41(4):981-6. PubMed ID: 23863167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A historical overview of protein kinases and their targeted small molecule inhibitors.
    Roskoski R
    Pharmacol Res; 2015 Oct; 100():1-23. PubMed ID: 26207888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide and structural analyses of pseudokinases encoded in the genome of Arabidopsis thaliana provide functional insights.
    Paul A; Srinivasan N
    Proteins; 2020 Dec; 88(12):1620-1638. PubMed ID: 32667690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric activation of functionally asymmetric RAF kinase dimers.
    Hu J; Stites EC; Yu H; Germino EA; Meharena HS; Stork PJS; Kornev AP; Taylor SS; Shaw AS
    Cell; 2013 Aug; 154(5):1036-1046. PubMed ID: 23993095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinases and pseudokinases: lessons from RAF.
    Shaw AS; Kornev AP; Hu J; Ahuja LG; Taylor SS
    Mol Cell Biol; 2014 May; 34(9):1538-46. PubMed ID: 24567368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF.
    Poulikakos PI; Zhang C; Bollag G; Shokat KM; Rosen N
    Nature; 2010 Mar; 464(7287):427-30. PubMed ID: 20179705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dimerization-dependent mechanism drives RAF catalytic activation.
    Rajakulendran T; Sahmi M; Lefrançois M; Sicheri F; Therrien M
    Nature; 2009 Sep; 461(7263):542-5. PubMed ID: 19727074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEK drives BRAF activation through allosteric control of KSR proteins.
    Lavoie H; Sahmi M; Maisonneuve P; Marullo SA; Thevakumaran N; Jin T; Kurinov I; Sicheri F; Therrien M
    Nature; 2018 Feb; 554(7693):549-553. PubMed ID: 29433126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of signaling in the kinome: Architecture and regulation of the αC Helix.
    Taylor SS; Shaw AS; Kannan N; Kornev AP
    Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1567-74. PubMed ID: 25891902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth.
    Hatzivassiliou G; Song K; Yen I; Brandhuber BJ; Anderson DJ; Alvarado R; Ludlam MJ; Stokoe D; Gloor SL; Vigers G; Morales T; Aliagas I; Liu B; Sideris S; Hoeflich KP; Jaiswal BS; Seshagiri S; Koeppen H; Belvin M; Friedman LS; Malek S
    Nature; 2010 Mar; 464(7287):431-5. PubMed ID: 20130576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK.
    Brennan DF; Dar AC; Hertz NT; Chao WC; Burlingame AL; Shokat KM; Barford D
    Nature; 2011 Apr; 472(7343):366-9. PubMed ID: 21441910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pickup in pseudokinase activity.
    Dar AC
    Biochem Soc Trans; 2013 Aug; 41(4):987-94. PubMed ID: 23863168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation that blocks ATP binding creates a pseudokinase stabilizing the scaffolding function of kinase suppressor of Ras, CRAF and BRAF.
    Hu J; Yu H; Kornev AP; Zhao J; Filbert EL; Taylor SS; Shaw AS
    Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6067-72. PubMed ID: 21441104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEK-1 phosphorylation by MEK kinase, Raf, and mitogen-activated protein kinase: analysis of phosphopeptides and regulation of activity.
    Gardner AM; Vaillancourt RR; Lange-Carter CA; Johnson GL
    Mol Biol Cell; 1994 Feb; 5(2):193-201. PubMed ID: 8019005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling.
    Dhawan NS; Scopton AP; Dar AC
    Nature; 2016 Sep; 537(7618):112-116. PubMed ID: 27556948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogen-activated protein kinase/extracellular signal-regulated protein kinase activation by oncogenes, serum, and 12-O-tetradecanoylphorbol-13-acetate requires Raf and is necessary for transformation.
    Troppmair J; Bruder JT; Munoz H; Lloyd PA; Kyriakis J; Banerjee P; Avruch J; Rapp UR
    J Biol Chem; 1994 Mar; 269(9):7030-5. PubMed ID: 8120067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of RAF Kinase Dimers Drives Conformational Changes that Facilitate Transactivation.
    Jambrina PG; Rauch N; Pilkington R; Rybakova K; Nguyen LK; Kholodenko BN; Buchete NV; Kolch W; Rosta E
    Angew Chem Int Ed Engl; 2016 Jan; 55(3):983-6. PubMed ID: 26644280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RAF inhibitor-induced KSR1/B-RAF binding and its effects on ERK cascade signaling.
    McKay MM; Ritt DA; Morrison DK
    Curr Biol; 2011 Apr; 21(7):563-8. PubMed ID: 21458265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudokinases repurpose flexibility signatures associated with the protein kinase fold for noncatalytic roles.
    Paul A; Subhadarshini S; Srinivasan N
    Proteins; 2022 Mar; 90(3):747-764. PubMed ID: 34708889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dual function of KSR1: a pseudokinase and beyond.
    Zhang H; Koo CY; Stebbing J; Giamas G
    Biochem Soc Trans; 2013 Aug; 41(4):1078-82. PubMed ID: 23863182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.